» Articles » PMID: 3104670

Age-related Differences in Plasmalogen Content of Erythrocytes from Patients with the Cerebro-hepato-renal (Zellweger) Syndrome: Implications for Postnatal Detection of the Disease

Overview
Publisher Wiley
Date 1986 Jan 1
PMID 3104670
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Phosphatidylethanolamine plasmalogen levels were determined in erythrocytes from controls and 13 patients with the cerebro-hepato-renal (Zellweger) syndrome. It was found that in Zellweger patients 20 weeks of age or younger, erythrocyte phosphatidylethanolamine plasmalogen levels were lowered whereas in older patients (except in one) normal levels were found. The results obtained suggest a close relationship between the age of the patients at sampling and the phosphatidylethanolamine plasmalogen levels in their erythrocytes. A possible explanation for these findings and the implications for the postnatal detection of Zellweger syndrome are discussed.

Citing Articles

Laboratory diagnosis of disorders of peroxisomal biogenesis and function: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

De Biase I, Tortorelli S, Kratz L, Steinberg S, Cusmano-Ozog K, Braverman N Genet Med. 2019; 22(4):686-697.

PMID: 31822849 DOI: 10.1038/s41436-019-0713-9.


Lipidomic analysis of fibroblasts from Zellweger spectrum disorder patients identifies disease-specific phospholipid ratios.

Herzog K, Pras-Raves M, Vervaart M, Luyf A, van Kampen A, Wanders R J Lipid Res. 2016; 57(8):1447-54.

PMID: 27284103 PMC: 4959860. DOI: 10.1194/jlr.M067470.


Contribution of fetal MR imaging in the prenatal diagnosis of Zellweger syndrome.

Mochel F, Grebille A, Benachi A, Martinovic J, Razavi F, Rabier D AJNR Am J Neuroradiol. 2006; 27(2):333-6.

PMID: 16484405 PMC: 8148762.


Assay of plasmalogens and polyunsaturated fatty acids (PUFA) in erythrocytes and fibroblasts.

dAcremont G, Vincent G J Inherit Metab Dis. 1995; 18 Suppl 1:84-9.

PMID: 9053558 DOI: 10.1007/BF00711431.


Zellweger syndrome: biochemical procedures in diagnosis, prevention and treatment.

Schutgens R, Wanders R, Heymans H, Schram A, Tager J, Schrakamp G J Inherit Metab Dis. 1987; 10 Suppl 1:33-45.

PMID: 3119940 DOI: 10.1007/BF01812845.


References
1.
Heymans H, vd Bosch H, Schutgens R, TEGELAERS W, Walther J, Muller-Hocker J . Deficiency of plasmalogens in the cerebro-hepato-renal (Zellweger) syndrome. Eur J Pediatr. 1984; 142(1):10-5. DOI: 10.1007/BF00442582. View

2.
HAJRA A, Burke C, Jones C . Subcellular localization of acyl coenzyme A: dihydroxyacetone phosphate acyltransferase in rat liver peroxisomes (microbodies). J Biol Chem. 1979; 254(21):10896-900. View

3.
Arias J, Moser A, Goldfischer S . Ultrastructural and cytochemical demonstration of peroxisomes in cultured fibroblasts from patients with peroxisomal deficiency disorders. J Cell Biol. 1985; 100(5):1789-92. PMC: 2113858. DOI: 10.1083/jcb.100.5.1789. View

4.
Wanders R, van Weringh G, Schrakamp G, Tager J, van den Bosch H, Schutgens R . Deficiency of acyl-CoA:dihydroxyacetone phosphate acyltransferase in thrombocytes of Zellweger patients: a simple postnatal diagnostic test. Clin Chim Acta. 1985; 151(3):217-21. DOI: 10.1016/0009-8981(85)90083-x. View

5.
HAJRA A, Bishop J . Glycerolipid biosynthesis in peroxisomes via the acyl dihydroxyacetone phosphate pathway. Ann N Y Acad Sci. 1982; 386:170-82. DOI: 10.1111/j.1749-6632.1982.tb21415.x. View